Advertisement

Managing Systems in Cardiac Remote Monitoring: A Complex Challenge Turned into an Important Clinical Tool

  • Mario OliveiraEmail author
  • Pedro S. Cunha
  • Nogueira da Silva
Conference paper
Part of the Communications in Computer and Information Science book series (CCIS, volume 511)

Abstract

With the increasing awareness of indications for cardiac devices, especially related to the clinical benefits of implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy (CRT), the number of patients with implanted electronic devices (CIED) has been growing steadily [1–3]. Recent data from the country members of the European Heart Rhythm Association (EHRA) have shown a general trend to increase in the number of centers implanting CIED, and, despite great differences in implanting rates among EHRA members, a steadily increase in the number of implants in almost all countries [4]. Consequently, more patients require regular follow-up to ascertain technical integrity.

Keywords

Heart Rate Variability Chronic Heart Failure Cardiac Resynchronization Therapy Remote Monitoring Chronic Heart Failure Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Stellbrink, C., Trappe, H.J.: The follow-up of cardiac devices: what to expect for the future? Eur. Heart J. Suppl. 9(Suppl. I), I113–I115 (2007)CrossRefGoogle Scholar
  2. 2.
    Stoepel, C., Boland, J., Busca, R., Saal, G., Oliveira, M.: Usefulness of remote monitoring in cardiac implantable device follow-up. Telemed J E Health. 15(10), 1026–1030 (2009)CrossRefGoogle Scholar
  3. 3.
    Marinskis, G., van Erven, L., Bongiorni, M.G., Lip, G.Y., Pison, L., Blomström-Lundqvist, C.: Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. Europace 14(3), 423–425 (2012)CrossRefGoogle Scholar
  4. 4.
    Arribas, F.: The EHRA White Book. Europace 14(Suppl. 3), ii1–ii55 (2012)Google Scholar
  5. 5.
    Joglar, J.A.: Remote monitoring of cardiovascular implantable electronic devices: new questions raised. Pacing Clin. Electrophysiol. 32(12), 1489–1491 (2010)CrossRefGoogle Scholar
  6. 6.
    Dubner, S., Auricchio, A., Steinberg, J.S., Vardas, P., Stone, P., Brugada, J., et al.: ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 14, 278–293 (2012)CrossRefGoogle Scholar
  7. 7.
    Tracy, C.M., et al.: 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. JACC 60(14), 1297–1313 (2012). Device-Based Therapy Guideline Focused Update October 2, 2012CrossRefGoogle Scholar
  8. 8.
    Sticherling, C., Kühne, M., Schaer, B., Altmann, D., Osswald, S.: Remote monitoring of cardiovascular implantable electronic devices. Prerequisite or luxury? Swiss Med Wkly 139(41–42), 596–601 (2009)Google Scholar
  9. 9.
    Wilkoff, B.L., Auricchio, A., Brugada, J., et al.: HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm. 5, 907–925 (2008)CrossRefGoogle Scholar
  10. 10.
    Raatikainen, M.J., Uusimaa, P., van Ginneken, M.M., et al.: Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost effective means for follow-up. Europace. 10, 1145–1151 (2008)CrossRefGoogle Scholar
  11. 11.
    Oliveira, M., Silva, P.C., Silva, N.: Remote monitoring for follow-up of patients with implantable cardiac devices. Rev. Port. Cardiol. 32, 185–190 (2013)Google Scholar
  12. 12.
    Landolina, M., Perego, G.B., Lunati, M., Curnis, A., Guenzati, G., Vicentini, A., Parati, G., Borghi, G., Zanaboni, P., Valsecchi, S., Marzegalli, M.: Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators. the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 125, 2985–2992 (2012)CrossRefGoogle Scholar
  13. 13.
    Burri, H.: Remote follow-up and continuous remote monitoring, distinguished. Europace 15, i14–i16 (2013)CrossRefGoogle Scholar
  14. 14.
    Kleeman, T., Becker, T., Doenges, K., Vater, M., Senges, J., Schneider, S., Saggau, W., Weisse, U., Seidl, K.: Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of > 10 years. Circulation 115, 2474–2480 (2007)CrossRefGoogle Scholar
  15. 15.
    Burri, H., Heidbüchel, H., Jung, W., Brugada, P.: Remote monitoring: a cost or an investment? Europace 13, ii44–ii48 (2011)Google Scholar
  16. 16.
    McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., et al.: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur. Heart J. 33, 1787–1847 (2012)CrossRefGoogle Scholar
  17. 17.
    Whellan, D.J., Ousdigian, K.T., Al-Khatib, S.M., et al.: Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J. Am. Coll. Cardiol. 55, 1803–1810 (2010)CrossRefGoogle Scholar
  18. 18.
    Sousa, C., Leite, S., Lagido, R., Ferreira, L., Silva-Cardoso, J., Maciel, M.J.: Telemonitoring in heart failure: a state-of-the-art review. Rev. Port. Cardiol. 33, 229–239 (2014)Google Scholar
  19. 19.
    Saxon, L.A., Hayes, D.L., Gilliam, F.R., Heidenreich, P.A., Day, J., Seth, M., Meyer, T.E., Jones, P.W., Boehmer, J.P.: Long-term outcome after ICD and CRT implantation and influence of remote device follow-up. the ALTITUDE survival study. Circulation 122, 2359–2367 (2010)CrossRefGoogle Scholar
  20. 20.
    Conraads, M., Tavazzi, L., Santini, M., et al.: Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur. Heart J. 32, 2266–2273 (2011)CrossRefGoogle Scholar
  21. 21.
    Adamson, P.B., Gold, M.R., Bennett, T., et al.: Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of the Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients with Chronic Heart Failure (REDUCEhf) trial. Congest Heart Fail. 17, 248–254 (2011)CrossRefGoogle Scholar
  22. 22.
    Braunschweig, F., Ford, I., Conraads, V., et al.: Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). Eur. J. Heart Fail 10, 907–916 (2008)CrossRefGoogle Scholar
  23. 23.
    Abraham, W.T., Compton, S., Haas, G., Foreman, B., Canby, R.C., Rishel, R., et al.: Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest. Heart Fail. 17(2), 51–55 (2011)CrossRefGoogle Scholar
  24. 24.
    Catanzariti, D., Lunati, M., Landolina, M., et al.: Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin. Electrophysiol. PACE 32, 363–370 (2009)CrossRefGoogle Scholar
  25. 25.
    Landolina, M., Perego, G.B., Lunati, M., et al.: Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) study. Circulation 125, 2985–2992 (2012)CrossRefGoogle Scholar
  26. 26.
    Conraads, V.M., Spruit, M.A., Braunschweig, F., Cowie, M.R., Tavazzi, L., Borggrefe, M., Hill, M.R.S., Jacobs, S., Gerritse, B., van Veldhuisen, D.J.: Physical activity, measured with implanted devices, predicts patient outcome in chronic heart failure. Circ. Heart Fail. 7(2), 279–287 (2014)CrossRefGoogle Scholar
  27. 27.
    Hindricks, G. et al.: IN-TIME: the influence of implant-based home monitoring on the clinical management of heart failure patients with an impaired left ventricular function. Eur. Heart J., 34(suppl 1) (2013)Google Scholar
  28. 28.
    Mittal, S. et al.: Increased adherence to remote monitoring is associated with reduced mortality in both pacemaker and defibrillator patients. Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions (2014)Google Scholar
  29. 29.
    Varma, N., Epstein, A.E., Irimpen, A., Schweikert, R., Love, C.: efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up. the Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) trial. Circulation 122, 325–332 (2010)CrossRefGoogle Scholar
  30. 30.
    Crossley, G., Boyle, A., Vitense, H., Chang, Y., Mead for the CONNECT Investigators, R.H.: The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial. the value of wireless remote monitoring with automatic clinician alerts. J. Am. Coll. Cardiol. 57, 1181–1189 (2011)CrossRefGoogle Scholar
  31. 31.
    Masella, C., Zanaboni, P., di Stasi, F., et al.: Assessment of a remote monitoring system for implantable cardioverter defibrillators. J. Telemed. Telecare 14, 290–294 (2008)CrossRefGoogle Scholar
  32. 32.
    Marzegalli, M., Lunati, M., Landolina, M., et al.: Remote monitoring of CRT–ICD: the multicenter Italian CareLink evaluation – ease of use, acceptance, and organizational implications. Pacing Clin. Electrophysiol. 31, 1259–1264 (2008)CrossRefGoogle Scholar
  33. 33.
    Klersy, C., De Silvestri, A., Gabutti, G., Raisaro, A., Curti, M., Regoli, F., Auricchio, A.: Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur. J. Heart Fail. 13(4), 450–459 (2011)CrossRefGoogle Scholar
  34. 34.
    Calò, L., Gargaro, A., De, R.E., Palozzi, G., Sciarra, L., Rebecchi, M., Guarracini, F., Fagagnini, A., Piroli, E., Lioy, E., Chirico, A.: Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits. A single-center prospective and randomized study. J. Interv. Card. Electrophysiol. 37(1), 69–78 (2013)CrossRefGoogle Scholar
  35. 35.
    Guedon-Moreau, L., Lacroix, D., Sadoul, N., Clementy, J., Kouakam, C., Hermida, J.-S., Aliot, E., Kacet, S., ECOST trial Investigators.: Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study. Europace. doi: 10.1093/europace/euu012
  36. 36.
    Costa, P.D., Rodrigues, P.P., Reis, A.H., et al.: A review on remote monitoring technology applied to implantable electronic cardiovascular devices. Telemed. J. E. Health 16, 1042–1050 (2010)CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Mario Oliveira
    • 1
    Email author
  • Pedro S. Cunha
    • 1
  • Nogueira da Silva
    • 1
  1. 1.Laboratory of Pacing and Electrophysiology, Cardiology DepartementSanta Marta HospitalLisbonPortugal

Personalised recommendations